214 related articles for article (PubMed ID: 19292801)
1. Identification and management of women at high risk for hereditary breast/ovarian cancer syndrome.
Ozanne EM; Loberg A; Hughes S; Lawrence C; Drohan B; Semine A; Jellinek M; Cronin C; Milham F; Dowd D; Block C; Lockhart D; Sharko J; Grinstein G; Hughes KS
Breast J; 2009; 15(2):155-62. PubMed ID: 19292801
[TBL] [Abstract][Full Text] [Related]
2. Hereditary breast-ovarian cancer: clinical findings and medical management.
Marshall M; Solomon S
Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
[TBL] [Abstract][Full Text] [Related]
3. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer.
Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L
Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771
[TBL] [Abstract][Full Text] [Related]
4. Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening.
Hoskins KF; Zwaagstra A; Ranz M
Cancer; 2006 Oct; 107(8):1769-76. PubMed ID: 16967460
[TBL] [Abstract][Full Text] [Related]
5. Genetic testing for breast and ovarian cancer for women with a family history of breast cancer: weighing conflicting evidence about oral contraceptives.
Friedenson B; Friedenson H
MedGenMed; 2002 Aug; 4(3):3. PubMed ID: 12466746
[No Abstract] [Full Text] [Related]
6. Cancer risk assessment and the genetic counseling process: using hereditary breast and ovarian cancer as an example.
Prucka SK; McIlvried DE; Korf BR
Med Princ Pract; 2008; 17(3):173-89. PubMed ID: 18408385
[TBL] [Abstract][Full Text] [Related]
7. Cancer risk assessment: quality and impact of the family history interview.
Murff HJ; Byrne D; Syngal S
Am J Prev Med; 2004 Oct; 27(3):239-45. PubMed ID: 15450637
[TBL] [Abstract][Full Text] [Related]
8. Genetic susceptibility to breast and ovarian cancer: risk assessment, genetic counseling, and management issues.
Shah MR
Mo Med; 2004; 101(2):105-10; quiz 110-1. PubMed ID: 15119107
[TBL] [Abstract][Full Text] [Related]
9. Genetic testing for breast and ovarian cancer susceptibility: a family experience.
Van Riper M; McKinnon WC
J Midwifery Womens Health; 2004; 49(3):210-9. PubMed ID: 15134674
[TBL] [Abstract][Full Text] [Related]
10. Establishing a family risk assessment clinic for breast cancer.
Mulsow J; Lee J; Dempsey C; Rothwell J; Geraghty JG
Breast J; 2009; 15 Suppl 1():S33-8. PubMed ID: 19775328
[TBL] [Abstract][Full Text] [Related]
11. An approach to the patient with a family history of breast cancer.
Kirk J; Brennan M; Houssami N; Ung O
Aust Fam Physician; 2006; 35(1-2):43-7. PubMed ID: 16489386
[TBL] [Abstract][Full Text] [Related]
12. [Counselling, genetic testing and prevention in women with hereditary breast- and ovarian cancer. Interdisciplinary recommendations of the consortium "Hereditary Breast- and Ovarian Cancer" of the German Cancer AiD].
Schmutzler R; Schlegelberger B; Meindl A; Gerber WD; Kiechle M;
Zentralbl Gynakol; 2003 Dec; 125(12):494-506. PubMed ID: 14755360
[TBL] [Abstract][Full Text] [Related]
13. Recall of and reactions to a surgeon referral letter for BRCA genetic counseling among high-risk breast cancer patients.
Vadaparampil ST; Quinn GP; Miree CA; Brzosowicz J; Carter B; Laronga C
Ann Surg Oncol; 2009 Jul; 16(7):1973-81. PubMed ID: 19408048
[TBL] [Abstract][Full Text] [Related]
14. Psychosocial impact of the lack of information given at referral about familial risk for cancer.
Metcalfe A; Werrett J; Burgess L; Clifford C
Psychooncology; 2007 May; 16(5):458-65. PubMed ID: 16933207
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk.
Wakefield CE; Meiser B; Homewood J; Peate M; Taylor A; Lobb E; Kirk J; Young MA; Williams R; Dudding T; Tucker K;
Breast Cancer Res Treat; 2008 Jan; 107(2):289-301. PubMed ID: 17333332
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial of a decision aid for women at increased risk of ovarian cancer.
Tiller K; Meiser B; Gaff C; Kirk J; Dudding T; Phillips KA; Friedlander M; Tucker K
Med Decis Making; 2006; 26(4):360-72. PubMed ID: 16855125
[TBL] [Abstract][Full Text] [Related]
17. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.
Forman AD; Hall MJ
Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331
[TBL] [Abstract][Full Text] [Related]
18. Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers.
Drohan B; Roche CA; Cusack JC; Hughes KS
Ann Surg Oncol; 2012 Jun; 19(6):1732-7. PubMed ID: 22427173
[TBL] [Abstract][Full Text] [Related]
19. Genetic risk assessment for breast and ovarian cancer.
O'Rourke Tiffen J; Pfeifer K; Fishman DA
Adv Nurse Pract; 2003 Oct; 11(10):40-8. PubMed ID: 14601495
[No Abstract] [Full Text] [Related]
20. Outpatient genetic risk assessment in women with breast cancer: one center's experience.
Washburn NJ; Sommer VK; Spencer SE; Simmons SK; Adkins BW; Rogers MR; Gerken PL; Bromley CM
Clin J Oncol Nurs; 2005 Feb; 9(1):49-53. PubMed ID: 15751498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
